A novel strategy towards the atorvastatin lactone

Tetrahedron

Volumn 66, Issue 51, 2010, Pages 9738-9744

  Sawant, Pramod ^a   Maier, Martin E ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

1,3 Diol; Allylation; Atorvastatin; Metalation; Pyrrole

Indexed keywords

1 (BENZYLOXY)HEX 5 EN 3 OL; 1 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYL] 2 (4 FLUOROPHENYL) 5 ISOPROPYL 3 PHENYL 1H PYRROLE; 1 [2 (BENZYLOXY)ETHYL]BUT 3 ENYL]OXY](TERT BUTYL)DIMETHYLSILANE; 1 [2 [ 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYL] 2 (4 FLUOROPHENYL) 4 IODO 5 ISOPROPYL 3 PHENYL 1H PYRROLE; 1 [2 [ 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYL] 5 (4 FLUOROPHENYL) 2 ISOPROPYL 4 PHENYL 1H PYRROLE 3 CARBOXYLIC ACID; 1 [2 [ 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYL] 5 (4 FLUOROPHENYL) 2 ISOPROPYL N,4 DIPHENYL 1H PYRROLE 3 CARBOXAMIDE; 4 (2 AZIDOETHYL) 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXANE; 4 ALLYL 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXANE; 5 (4 FFUOROPHENYL) 1 [2 [ 6 (2-HYDROXYETHYL) 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYL] 2 ISOPROPYL N,4 DIPHENYL 1H PYRROLE 3 CARBOXAMIDE; 5 (4 FLUOROPHENYL) 1 [2 (4 HYDROXY 6 OXO TETRAHYDROPYRAN 2 YL) ETHYL] 2 ISOPROPYL 4 PHENYL 1H PYRROLE 3 CARBOXYLIC ACID PHENYLAMIDE; 5 (BENZYLOXY) 3 [[TERT BUTYL(DIMETHYL)SILYL]OXY] PENTAN 1 OL; 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHANOL; 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYL 4 METHYLBENZENESULFONATE; 6 [2 (BENZYLOXY)ETHYL] 2,2 DIMETHYL 1,3 DIOXAN 4 YL]ETHYLAMINE; 8 (BENZYLOXY) 6 [[TERT BUTYL(DIMETHYL)SILYL]OXY] OCT 1 EN 4 OL; [6 [2 [2 (4 FLUOROPHENYL) 5 ISOPROPYL 3 PHENYL 4 PHENYLCARBAMOYL PYRROL 1 YL] ETHYL] 2,2 DIMETHYL [1,3] DIOXAN 4 YL] ACETIC ACID; AMINE; ATORVASTATIN; DIKETONE; LACTONE DERIVATIVE; PYRROLE; UNCLASSIFIED DRUG;

ARTICLE; CARBOXYLATION; CHEMICAL REACTION; DEBENZYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; IODINATION; LACTONIZATION; OXIDATION; PRIORITY JOURNAL;

EID: 78650209228     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2010.10.028     Document Type: Article

References (52)

1. For a review, see: J.A. Tobert Nat. Rev. Drug Discovery 2 2003 517 526
2. M. Schachter Br. J. Diabetes Vasc. Dis. 3 2003 178 182
3. J. Davignon Circulation 109 2004 III/39 III/43
4. J.L. Martin-Ventura, L.M. Blanco-Colio, A. Gomez-Hernandez, B. Munoz-Garcia, M. Vega, J. Serrano, L. Ortega, G. Hernandez, J. Tunon, and J. Egido Stroke 36 2005 1796 1800
5. C. Torrens, C.J. Kelsall, L.A. Hopkins, F.W. Anthony, N.P. Curzen, and M.A. Hanson Hypertension 53 2009 661 667, and references therein
6. G. Weitz-Schmidt, K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel Nat. Med. 7 2001 687 692
7. Laufer, S. University of Tübingen, Pharmaceutical Chemistry, Personal Communication.
8. E.S. Istvan, and J. Deisenhofer Science 292 2001 1160 1164
9. See, for example: H. Daub Biochim. Biophys. Acta 1754 2005 183 190
10. B.J. Leslie, and P.J. Hergenrother Chem. Soc. Rev. 37 2008 1347 1360
11. S.-i. Sato, A. Murata, T. Shirakawa, and M. Uesugi Chem. Biol. 17 2010 616 623
12. B.D. Roth, C.J. Blankley, A.W. Chucholowski, E. Ferguson, M.L. Hoefle, D.F. Ortwine, R.S. Newton, C.S. Sekerke, D.R. Sliskovic, C.D. Stratton, and M.W. Wilson J. Med. Chem. 34 1991 357 366
13. K.L. Baumann, D.E. Butler, C.F. Deering, K.E. Mennen, A. Millar, T.N. Nanninga, C.W. Palmer, and B.D. Roth Tetrahedron Lett. 33 1992 2283 2284
14. R. Oehrlein, and G. Baisch Adv. Synth. Catal. 345 2003 713 715
15. S. Radl Synth. Commun. 33 2003 2275 2283
16. A.K. Ghosh, and H. Lei J. Org. Chem. 65 2000 4779 4781
17. V.I. Tararov, N. Andrushko, V. Andrushko, G. Koenig, A. Spannenberg, and A. Boerner Eur. J. Org. Chem. 2006 5543 5550
18. S. George, and A. Sudalai Tetrahedron Lett. 48 2007 8544 8546
19. For some reviews, see:
20. M. Müller Angew. Chem. 117 2005 366 369
21. Angew. Chem., Int. Ed. 44 2005 362 365
22. J.M. Patel J. Mol. Catal. B: Enzym. 61 2009 123 128
23. H. Asako, M. Shimizu, and N. Itoh Appl. Microbiol. Biotechnol. 84 2009 397 405
24. S. Bergeron, D.A. Chaplin, J.H. Edwards, B.S.W. Ellis, C.L. Hill, K. Holt-Tiffin, J.R. Knight, T. Mahoney, A.P. Osborne, and G. Ruecroft Org. Process Res. Dev. 10 2006 661 665
25. F. Sun, G. Xu, J. Wu, and L. Yang Tetrahedron: Asymmetry 18 2007 2454 2461
26. J. Liu, C.-C. Hsu, and C.-H. Wong Tetrahedron Lett. 45 2004 2439 2441
27. W.A. Greenberg, A. Varvak, S.R. Hanson, K. Wong, H. Huang, P. Chen, and M.J. Burk Proc. Natl. Acad. Sci. U.S.A. 101 2004 5788 5793
28. G. Beck, H. Jendralla, and K. Kesseler Synthesis 1995 1014 1018
29. G. Wess, K. Kesseler, E. Baader, W. Bartmann, G. Beck, A. Bergmann, H. Jendralla, K. Bock, O. Holzstein, H. Kleine, and M. Schnierer Tetrahedron Lett. 31 1990 2545 2548
30. See, for example:
31. Butler, D.E., Le, T.V., Nanninga, T.N. U.S. Patent 5,298,627 1994, 19 pp; CAN, 121, 57333.
32. Sattigeri, J.A., Salman, M., Rawat, S., Sethi, S. In PCT Int. Appl. (Ranbaxy Laboratories Limited, India). WO patent appl. 118536, 2005, 24 pp; CAN, 144, 51375.
33. N.Z. Burns, P.S. Baran, and R.W. Hoffmann Angew. Chem. 121 2009 2896 2910
34. Angew. Chem., Int. Ed. 48 2009 2854 2867
35. See, for example:
36. J.M. Schomaker, V.R. Pulgam, and B. Borhan J. Am. Chem. Soc. 126 2004 13600 13601
37. L.V. Heumann, and G.E. Keck Org. Lett. 9 2007 1951 1954
38. A. Hassan, Y. Lu, and M.J. Krische Org. Lett. 11 2009 3112 3115
39. Y. Lu, and M.J. Krische Org. Lett. 11 2009 3108 3111
40. Org. Lett. 11 2009 5362 (correction)
41. Y.G. Gololobov, I.N. Zhmurova, and L.F. Kasukhin Tetrahedron 37 1981 437 472
42. W.Q. Tian, and Y.A. Wang J. Org. Chem. 69 2004 4299 4308
43. For the bromination of related pyrrols, see:
44. P.A. Procopiou, C.D. Draper, J.L. Hutson, G.G.A. Inglis, B.C. Ross, and N.S. Watson J. Med. Chem. 36 1993 3658 3662
45. L.D. Bratton, B. Auerbach, C. Choi, L. Dillon, J.C. Hanselman, S.D. Larsen, G. Lu, K. Olsen, J.A. Pfefferkorn, A. Robertson, C. Sekerke, B.K. Trivedi, and P.C. Unangst Bioorg. Med. Chem. 15 2007 5576 5589
46. Garcia Chapinal, F., Asensio Dominguez, R., Cruzado Rodriguez, M.C., Herradon Garcia, B., Chicharro Martin, R. Span. Patent 2,289,945, 2008, 25 pp; CAN, 148, 561631.
47. J. Coste, E. Frérot, P. Jouin, and B. Castro Tetrahedron Lett. 32 1991 1967 1970
48. J. Coste, E. Frerot, and P. Jouin J. Org. Chem. 59 1994 2437 2446
49. For a review about peptide bond formation, see: S.-Y. Han, and Y.-A. Kim Tetrahedron 60 2004 2447 2467
50. S. Hanessian, T.J. Liak, and B. Vanasse Synthesis 1981 396 397
51. B.S. Bal, W.E. Childers, and H.W. Pinnick Tetrahedron 37 1981 2091 2096
52. J. Stach, J. Havlicek, L. Placek, and S. Radl Collect. Czech. Chem. Commun. 73 2008 229 246